How to buy CollPlant Biotechnologies stock - 21 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CollPlant Biotechnologies stock

Own CollPlant Biotechnologies stock in just a few minutes.

CollPlant Biotechnologies Ltd is a biotechnology business based in the US. CollPlant Biotechnologies shares (CLGN) are listed on the NASDAQ and all prices are listed in US Dollars. CollPlant Biotechnologies employs 38 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in CollPlant Biotechnologies

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CLGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

CollPlant Biotechnologies share price

Use our graph to track the performance of CLGN stocks over time.

CollPlant Biotechnologies shares at a glance

Information last updated 2021-03-18.
52-week range$6.19 - $24.26
50-day moving average $16.57
200-day moving average $10.95
Wall St. target price$23.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.82

Buy CollPlant Biotechnologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy CollPlant Biotechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

CollPlant Biotechnologies financials

Revenue TTM $6 million
Gross profit TTM $439,000
Return on assets TTM -26.72%
Return on equity TTM -267.78%
Profit margin -122.41%
Book value $1.05
Market capitalisation $123.8 million

TTM: trailing 12 months

Shorting CollPlant Biotechnologies shares

There are currently 3,188 CollPlant Biotechnologies shares held short by investors – that's known as CollPlant Biotechnologies's "short interest". This figure is 7% up from 2,980 last month.

There are a few different ways that this level of interest in shorting CollPlant Biotechnologies shares can be evaluated.

CollPlant Biotechnologies's "short interest ratio" (SIR)

CollPlant Biotechnologies's "short interest ratio" (SIR) is the quantity of CollPlant Biotechnologies shares currently shorted divided by the average quantity of CollPlant Biotechnologies shares traded daily (recently around 318800). CollPlant Biotechnologies's SIR currently stands at 0.01. In other words for every 100,000 CollPlant Biotechnologies shares traded daily on the market, roughly 10 shares are currently held short.

However CollPlant Biotechnologies's short interest can also be evaluated against the total number of CollPlant Biotechnologies shares, or, against the total number of tradable CollPlant Biotechnologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CollPlant Biotechnologies's short interest could be expressed as 0% of the outstanding shares (for every 100,000 CollPlant Biotechnologies shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable CollPlant Biotechnologies shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CollPlant Biotechnologies.

Find out more about how you can short CollPlant Biotechnologies stock.

CollPlant Biotechnologies share dividends

We're not expecting CollPlant Biotechnologies to pay a dividend over the next 12 months.

Have CollPlant Biotechnologies's shares ever split?

CollPlant Biotechnologies's shares were split on a 2:3 basis on 20 November 2016. So if you had owned 3 shares the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CollPlant Biotechnologies shares – just the quantity. However, indirectly, the new 50% higher share price could have impacted the market appetite for CollPlant Biotechnologies shares which in turn could have impacted CollPlant Biotechnologies's share price.

CollPlant Biotechnologies share price volatility

Over the last 12 months, CollPlant Biotechnologies's shares have ranged in value from as little as $6.185 up to $24.26. A popular way to gauge a stock's volatility is its "beta".

CLGN.US volatility(beta: 0.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CollPlant Biotechnologies's is 0.6322. This would suggest that CollPlant Biotechnologies's shares are less volatile than average (for this exchange).

CollPlant Biotechnologies overview

CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bio-printing of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants; VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site